{"id":3547,"count":1,"description":"Polycystisk ovariesyndrom (PCOS) er den hyppigste endokrine lidelse hos kvinder i den fertile alder, karakteriseret ved oligo-\/anovulation, hyperandrogenisme (akne, hirsutisme) og polycystisk ovarie-morfologi p\u00e5 ultralyd. Moderne behandling retter sig mod den dominerende kliniske bekymring \u2014 cyklusregulering, fertilitet, hirsutisme\/akne, insulinresistens\/metabolisk risiko \u2014 med forskellige midler til forskellige m\u00e5l.\n\n<strong>P\u00e5 lager.<\/strong> Medroxyprogesteron (oral progestogen til cyklusregulering hos kvinder, der ikke \u00f8nsker pr\u00e6vention eller graviditet \u2014 typisk 10 mg dagligt i 10\u201314 dage ved starten af hver cyklus for at inducere menstruation hver 1\u20133 m\u00e5neder og beskytte endometriet mod umodst\u00e5et \u00f8strogen) er p\u00e5 lager som <a href=\"https:\/\/medsbase.com\/da\/deviry\/\">Deviry<\/a>.\n\n<strong>For andre PCOS-m\u00e5l \u2014 se relaterede kategorier.<\/strong> Kombinerede orale pr\u00e6ventionspiller (COCP) til cyklusregulering + akne\/hirsutisme + pr\u00e6vention \u2192 <a href=\"https:\/\/medsbase.com\/da\/contraceptive-pill-the-pill\/\">P-pillekatalog<\/a> (drospirenon-baserede piller som Yaz eller Yasmin som f\u00f8rstevalg; cyproteron-acetat-indeholdende Diane 35 til moderat-sv\u00e6r akne\/hirsutisme). Metformin til insulinresistens + cyklusregulering + beskeden v\u00e6gtreducerende effekt \u2192 <a href=\"https:\/\/medsbase.com\/da\/diabetes-medication\/\">Diabetesmedicin<\/a>. Anti-androgener (spironolakton, cyproteron) til hirsutisme \u2014 konsulter receptpligtig udskriver. Ovulationsinduktion til PCOS-infertilitet (klomifen, letrozol, gonadotropiner) \u2192 <a href=\"https:\/\/medsbase.com\/da\/fertility-supplements-for-women\/\">Fertilitetstilskud til kvinder<\/a>. Topikal aknebehandling \u2192 <a href=\"https:\/\/medsbase.com\/da\/acne-treatment\/\">Behandling af acne<\/a>.\n\n<strong>Vigtigt.<\/strong> PCOS is a clinical diagnosis (Rotterdam criteria \u2014 2 of 3: oligo-\/anovulation, hyperandrogenism, polycystic ovaries) \u2014 exclude pregnancy, thyroid dysfunction, hyperprolactinaemia, congenital adrenal hyperplasia, Cushing's syndrome before diagnosis. Long-term cardiovascular and metabolic risk (type 2 diabetes, hypertension, sleep apnoea, NAFLD, endometrial cancer) is increased \u2014 annual review of weight, BP, lipids, HbA1c recommended. Weight loss of 5\u201310% (where applicable) restores ovulation in many women. Endometrial protection (regular withdrawal bleeds at least every 3 months) matters in women with prolonged amenorrhoea. All MedsBase products ship from <strong>WHO-GMP certificerede producenter<\/strong> med diskret emballage og er d\u00e6kket af vores <a href=\"https:\/\/medsbase.com\/da\/medsbase-re-shipment-assurance-policy\/\">Reshipment Assurance Policy<\/a>.","link":"https:\/\/medsbase.com\/da\/pcos-treatment\/","name":"PCOS-behandling","slug":"pcos-treatment","taxonomy":"product_cat","parent":3502,"meta":[],"menu_order":0,"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product_cat\/3547","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product_cat"}],"about":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/taxonomies\/product_cat"}],"up":[{"embeddable":true,"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product_cat\/3502"}],"wp:post_type":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product?product_cat=3547"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}